Concepedia

Katie Zomorodi

KZ

Statistics

Publications

12

Citations

395

H-Index

12

Active since

2002

Affiliations

Jazz Pharmaceuticals (United States)(Current)

Quest Research Institute

University of South Florida

Xenobe Research Institute

Henry Ford Hospital

Katie Zomorodi is an author at Jazz Pharmaceuticals (United States) specializing in pharmacology, clinical pharmacology, and pharmacokinetics.

Publications per year

2002–2021

12

Publications

12

Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid tumors: a pediatric oncology group study.

Neyssa Marina, Debon Cochrane, Elaine Harney et al. · PubMed · 2002 · 101 citations

, , +17

Double‐blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease

Peter A. LeWitt, F. Jacob Huff, Robert A. Hauser et al. · Movement Disorders · 2013 · 58 citations

, , +15

A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study to Assess the Pharmacokinetics, Efficacy, and Safety of Gabapentin Enacarbil in Subjects With Restless Legs Syndrome

Ritu Lal, Aaron Ellenbogen, Dan Chen et al. · Clinical Neuropharmacology · 2012 · 43 citations

, , +14

Actively Transported Levodopa Prodrug XP21279

Peter A. LeWitt, Aaron Ellenbogen, Dan Chen et al. · Clinical Neuropharmacology · 2012 · 36 citations

, , +17

A Phase I, Randomized, Crossover, Open-label Study of the Pharmacokinetics of Solriamfetol (JZP-110) in Healthy Adult Subjects With and Without Food

Katie Zomorodi, Martin Kankam, Yuan Lü · Clinical Therapeutics · 2018 · 27 citations · Full text

, , +15

1–5 of 12